Pacira Pharma (PCRX) Reports FDA Advisory Committee Meeting to Review sNDA for EXPAREL
Tweet Send to a Friend
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that the U.S. Food and Drug Administration (FDA) has notified the company that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE